Literature DB >> 26998091

Combination of lactate calcium salt with 5-indanesulfonamide and α-cyano-4-hydroxycinnamic acid to enhance the antitumor effect on HCT116 cells via intracellular acidification.

Keun-Yeong Jeong1, Poonam Mander1, Jae Jun Sim1, Hwan Mook Kim1.   

Abstract

Maintenance of a neutral intracellular pH (pHi) is favorable for the survival of tumors, and maintenance of highly acidic extracellular pH (pHe) facilitates tumor invasiveness. The aim of the present study was to investigate the antitumor effects of lactate calcium salt (CaLa), 5-indanesulfonamide (IS) and α-cyano-4-hydroxycinnamic acid (CA) via pH regulation in colon cancer cells. HCT116 cells were treated with CaLa, IS, CA and combinations of the three. Subsequently, the concentration of intracellular lactate was determined. pHi and pHe were measured using cell lysates and culture media. Colony formation assay, cell viability assay and western blot analysis were additionally performed to analyze the consequences of the pH changes. CaLa, IS, CA and combination treatments induced an increase in the concentration of intracellular lactate. Lactate influx into the tumor microenvironment produced an acidic pHi in colon cancer cells. Consequently, colony formation and cell viability were significantly decreased, as well as poly(adenosine diphosphate-ribose) polymerase degradation. The tumor microenvironment may be exploited therapeutically by disrupting the mechanism that regulates pHi, leading to cell apoptosis. The present study indicated that treatment with CaLa, IS and CA induced intracellular acidification via lactate influx, causing apoptosis of colon cancer cells. Additionally, the findings suggested that the combination of CaLa with IS and CA may enhance antitumor activity, and may provide a potential therapeutic approach for the treatment of colon cancer.

Entities:  

Keywords:  antitumor effect; carbonic anhydrase 9; cellular pH; colon cancer; lactate calcium salt; monocarboxylate transporter 4

Year:  2016        PMID: 26998091      PMCID: PMC4774552          DOI: 10.3892/ol.2016.4137

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  30 in total

1.  Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.

Authors:  Nadia Touisni; Alfonso Maresca; Paul C McDonald; Yuanmei Lou; Andrea Scozzafava; Shoukat Dedhar; Jean-Yves Winum; Claudiu T Supuran
Journal:  J Med Chem       Date:  2011-11-22       Impact factor: 7.446

Review 2.  Alterations of intracellular pH homeostasis in apoptosis: origins and roles.

Authors:  D Lagadic-Gossmann; L Huc; V Lecureur
Journal:  Cell Death Differ       Date:  2004-09       Impact factor: 15.828

3.  Colorectal cancer statistics, 2014.

Authors:  Rebecca Siegel; Carol Desantis; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2014-03-17       Impact factor: 508.702

Review 4.  Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal.

Authors:  Mi Young Kim; Tong Zhang; W Lee Kraus
Journal:  Genes Dev       Date:  2005-09-01       Impact factor: 11.361

5.  Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner.

Authors:  K S Lim; K J Lim; A C Price; B A Orr; C G Eberhart; E E Bar
Journal:  Oncogene       Date:  2013-09-30       Impact factor: 9.867

6.  Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.

Authors:  Alan McIntyre; Shalini Patiar; Simon Wigfield; Ji-Liang Li; Ioanna Ledaki; Helen Turley; Russell Leek; Cameron Snell; Kevin Gatter; William S Sly; Richard D Vaughan-Jones; Pawel Swietach; Adrian L Harris
Journal:  Clin Cancer Res       Date:  2012-04-12       Impact factor: 12.531

7.  Bicarbonate, NBCe1, NHE, and carbonic anhydrase activity enhance lactate-H+ transport in bovine corneal endothelium.

Authors:  Tracy T Nguyen; Joseph A Bonanno
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

8.  Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer.

Authors:  Yoshifumi Nakayama; Takayuki Torigoe; Yuzuru Inoue; Noritaka Minagawa; Hiroto Izumi; Kimitoshi Kohno; Koji Yamaguchi
Journal:  Exp Ther Med       Date:  2011-10-07       Impact factor: 2.447

9.  The role of carbonic anhydrase 9 in regulating extracellular and intracellular ph in three-dimensional tumor cell growths.

Authors:  Pawel Swietach; Shalini Patiar; Claudiu T Supuran; Adrian L Harris; Richard D Vaughan-Jones
Journal:  J Biol Chem       Date:  2009-05-19       Impact factor: 5.157

10.  Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.

Authors:  Yukito Gotanda; Yoshito Akagi; Akihiko Kawahara; Tetsushi Kinugasa; Takefumi Yoshida; Yasuhiko Ryu; Ichitaro Shiratsuchi; Masayoshi Kage; Kazuo Shirouzu
Journal:  Anticancer Res       Date:  2013-07       Impact factor: 2.480

View more
  2 in total

1.  Conformational Differentiation of α-Cyanohydroxycinnamic Acid Isomers: A Raman Spectroscopic Study.

Authors:  Jayson Vedad; Maciej E Domaradzki; Elmer-Rico E Mojica; Emmanuel J Chang; Adam A Profit; Ruel Z B Desamero
Journal:  J Raman Spectrosc       Date:  2017-07-27       Impact factor: 3.133

2.  Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism.

Authors:  Simone Kumstel; Tim Schreiber; Lea Goldstein; Jan Stenzel; Tobias Lindner; Markus Joksch; Xianbin Zhang; Edgar Heinz Uwe Wendt; Maria Schönrogge; Bernd Krause; Brigitte Vollmar; Dietmar Zechner
Journal:  PLoS One       Date:  2022-04-22       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.